Jill Wu's Stock Coverage
| 6127JOINN Laboratories (China) Co., Ltd. Class H | Oct 30, 2026 | BUY | Reiterated | HK$30.00 | 7Ratings | +21.70% | ||
| 15303SBio | Oct 29, 2026 | BUY | Reiterated | HK$34.78 | 12Ratings | +88.67% | ||
| 9969InnoCare Pharma Ltd. | Oct 28, 2026 | BUY | Reiterated | HK$18.90 | 5Ratings | +18.22% | ||
| 9606Duality Biotherapeutics, Inc. | Oct 28, 2026 | BUY | Reiterated | HK$284.50 | 5Ratings | -31.86% | ||
| 6990Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H | Oct 27, 2026 | BUY | Reiterated | HK$642.29 | 11Ratings | +68.46% | ||
| 1801Innovent Biologics | Oct 27, 2026 | BUY | Reiterated | HK$138.63 | 16Ratings | +40.31% | ||
| TMOThermo Fisher | Oct 23, 2026 | BUY | Reiterated | $800.00 | 9Ratings | +18.21% | ||
| 3692Hansoh Pharmaceutical Group Company Limited | Oct 21, 2026 | BUY | Reiterated | HK$50.54 | 10Ratings | +38.06% | ||
| 2637Fujian Haixi Pharmaceuticals Co., Ltd. Class H | Sep 18, 2026 | BUY | Reiterated | HK$280.00 | 2Ratings | -24.55% | ||
| 6699Angelalign Technology Inc. | Sep 02, 2026 | BUY | Reiterated | HK$114.21 | 5Ratings | +21.48% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Jill Wu activity FAQ
What is the performance of Jill Wu's recommendations?
The percentage of profitable recommendations made by Jill Wu is 53.00%, and the average return per transaction is 23.40%.
What stocks does Jill Wu cover?
Jill Wu mostly covers JOINN Laboratories (China) Co., Ltd. Class H, 3SBio, Duality Biotherapeutics, Inc. stocks.
What was Jill Wu's most profitable rating?
Jill Wu’s most profitable rating was a buy on RemeGen Co. Ltd. Class H stock on Aug 19, 2024. The return on the trade was 459.40%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here